- 全部删除
您的购物车当前为空
Simtuzumab 是一种针对赖氨酰氧化酶样蛋白 2 (LOXL2) 的单克隆抗体。Simtuzumab 可用于治疗原发性硬化性胆管炎 (PSC),对非酒精性脂肪性肝炎引起的桥接性纤维化或代偿性肝硬化患者无效 。

为众多的药物研发团队赋能,
让新药发现更简单!
Simtuzumab 是一种针对赖氨酰氧化酶样蛋白 2 (LOXL2) 的单克隆抗体。Simtuzumab 可用于治疗原发性硬化性胆管炎 (PSC),对非酒精性脂肪性肝炎引起的桥接性纤维化或代偿性肝硬化患者无效 。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 1,650 | In stock | |
| 5 mg | ¥ 4,970 | In stock | |
| 10 mg | ¥ 6,880 | In stock | |
| 25 mg | ¥ 9,870 | In stock | |
| 50 mg | ¥ 13,700 | In stock | |
| 100 mg | ¥ 18,500 | In stock |
Simtuzumab 相关产品
| 产品描述 | Simtuzumab is a monoclonal antibody against lysyl oxidase-like protein 2 (LOXL2). Simtuzumab can be used to treat primary sclerosing cholangitis (PSC) and is not effective in patients with bridging fibrosis or compensatory cirrhosis caused by non-alcoholic steatohepatitis. |
| 别名 | 辛妥珠单抗, GS 6624, AB 0024 |
| 分子量 | 150.00 kDa |
| CAS No. | 1318075-13-6 |
| 颜色 | Transparent |
| 物理性状 | Liquid |
| 存储 | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
评论内容